Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

CDNA

Caredx Inc

Feb 11 • 04:00PM ET

19.72

-0.85 -4.13 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: NTRA ILMN FLGT GH EXAS TWST VRTX CRSP TXG QGEN

| Held by: ARKG XBI VTI IWM VXF IWO IBB SCHA VTWO JSMD

Index	RUT	P/E	16.54	EPS (ttm)	1.19	Insider Own	10.86%	Shs Outstand	51.41M	Perf Week	4.17%
Market Cap	1.01B	Forward P/E	-	EPS next Y	-0.01	Insider Trans	-0.78%	Shs Float	45.84M	Perf Month	-4.13%
Enterprise Value	847.67M	PEG	-	EPS next Q	0.02	Inst Own	100.50%	Short Float	12.55%	Perf Quarter	18.08%
Income	70.45M	P/S	2.83	EPS this Y	-132.08%	Inst Trans	0.34%	Short Ratio	7.44	Perf Half Y	58.27%
Sales	358.00M	P/B	3.26	EPS next Y	96.09%	ROA	15.50%	Short Interest	5.75M	Perf YTD	4.67%
Book/sh	6.05	P/C	5.22	EPS next 5Y	-	ROE	24.11%	52W High	25.55 -22.82%	Perf Year	-13.55%
Cash/sh	3.78	P/FCF	27.35	EPS past 3/5Y	- -	ROIC	21.20%	52W Low	10.96 79.93%	Perf 3Y	28.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.04% 21.31%	Gross Margin	66.92%	Volatility	6.91% 5.28%	Perf 5Y	-78.04%
Dividend TTM	-	EV/Sales	2.37	EPS Y/Y TTM	148.22%	Oper. Margin	-7.01%	ATR (14)	1.13	Perf 10Y	289.16%
Dividend Ex-Date	-	Quick Ratio	2.75	Sales Y/Y TTM	14.46%	Profit Margin	19.68%	RSI (14)	49.27	Recom	2.11
Dividend Gr. 3/5Y	- -	Current Ratio	3.03	EPS Q/Q	122.29%	SMA20	-2.58%	Beta	2.51	Target Price	24.00
Payout	0.00%	Debt/Eq	0.09	Sales Q/Q	20.72%	SMA50	0.63%	Rel Volume	1.02	Prev Close	20.57
Employees	650	LT Debt/Eq	0.07	Earnings	Feb 24 AMC	SMA200	18.88%	Avg Volume	773.03K	Price	19.72
IPO	Jul 17, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	136.63% 4.91%	Trades		Volume	787,943	Change	-4.13%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-26	Downgrade	Craig Hallum	Buy → Hold	$26
Aug-26-25	Initiated	William Blair	Mkt Perform
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$28 → $24
Aug-28-24	Initiated	Wells Fargo	Underweight	$28
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy	$40
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45

Show Previous Ratings

Feb-10-26 04:01PM	CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (Business Wire)
Feb-03-26 07:05AM	CareDx to Present AlloHeme Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings (Business Wire)
Jan-27-26 04:05PM	CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-13-26 10:45AM	NTRA & NVDA Partner to Improve AI Models for Precision Medicine (Zacks)
08:30AM	Implied Volatility Surging for CareDx Stock Options (Zacks)
08:57AM	Loading…
Jan-12-26 08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks) +20.08%
07:05AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Jan-07-26 07:05AM	CareDx and 10x Genomics to Launch ImmuneScape Program - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response (Business Wire)
Jan-06-26 10:48AM	Cigna Shares on the Couch: Time to Stay Strong or Walk Away Now? (Zacks) -5.05%
Dec-26-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-18-25 05:00PM	CareDx Provides Notice of Proposed Derivative Settlement (Business Wire)
Nov-27-25 09:55AM	Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade (Zacks)
Nov-24-25 04:05PM	SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation (Business Wire)
Nov-07-25 04:05PM	CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.91%
08:00AM	Loading…
Nov-06-25 08:00AM	CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 (Business Wire) -9.20%
Nov-05-25 12:03AM	CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance (GuruFocus.com) +13.84%
Nov-04-25 07:00PM	CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM	CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:12PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 07:52AM	CareDx Inc (CDNA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-27-25 07:05AM	CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer (Business Wire)
Oct-23-25 04:05PM	CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure (Business Wire)
Oct-22-25 04:01PM	CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors (Business Wire)
Oct-21-25 08:00AM	CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025 (Business Wire)
Oct-06-25 07:05AM	CareDx Announces New IVD Products and IVDR Certification for AlloSeq Tx and QTYPE at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting (Business Wire)
Sep-02-25 04:01PM	CareDx Issues Comment Letter on Draft LCD Policy (Business Wire) -8.09%
Aug-26-25 01:08PM	CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential (Benzinga)
Aug-22-25 08:30AM	Do Options Traders Know Something About CareDx Stock We Don't? (Zacks)
04:01PM	Loading…
Aug-21-25 04:01PM	CareDx to Participate in Wells Fargo Healthcare Conference (Business Wire)
Aug-12-25 08:00AM	Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors (Business Wire) +5.86%
Aug-06-25 06:30PM	Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings (Zacks) -7.86%
05:45PM	CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates (Zacks)
04:57PM	CareDx Announces Appointment of Nathan Smith as Chief Financial Officer (Business Wire)
04:43PM	CareDx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	CareDx Announces Second Quarter 2025 Financial Results (Business Wire)
12:56PM	CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation (Business Wire)
Aug-05-25 10:07AM	What To Expect From CareDx Inc (CDNA) Q2 2025 Earnings (GuruFocus.com)
Jul-31-25 04:01PM	CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress (Business Wire)
Jul-23-25 07:05AM	CareDx to Report Second Quarter 2025 Financial Results (Business Wire)
Jul-22-25 07:06AM	CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Jul-18-25 08:00AM	CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection (Business Wire)
Jun-03-25 04:30PM	CareDx Announces Repurchase of 5% of Outstanding Shares (Business Wire) +10.67%
May-13-25 04:01PM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-01-25 03:17AM	CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments (GuruFocus.com) -10.72%
Apr-30-25 08:39PM	CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.89%
05:50PM	CareDx (CDNA) Tops Q1 Earnings Estimates (Zacks)
04:50PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2025 Results (Business Wire)
Apr-29-25 07:05AM	CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-24-25 07:05AM	CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-21-25 04:01PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-08-25 07:05AM	CareDx to Report First Quarter 2025 Financial Results (Business Wire)
Apr-04-25 12:40PM	Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock? (Zacks)
Mar-11-25 07:05AM	CareDx Launches Two Expanded Indications for AlloSure Testing Services (Business Wire)
Feb-27-25 02:20AM	CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 07:00PM	CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:56PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-25-25 10:39AM	CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:05AM	CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict (Business Wire)
Feb-20-25 07:05AM	CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients (Business Wire) -5.34%
Feb-13-25 07:05AM	CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies (Business Wire)
Feb-11-25 07:05AM	CareDx to Report Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -8.43%
03:22AM	CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? (Zacks)
Feb-10-25 02:51PM	Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj (CNBC TV) +11.16%
02:51PM	Final Trades: NRG Energy, MP Materials, CareDx and Applovin (CNBC TV)
Feb-05-25 09:55AM	Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? (Zacks)
Jan-29-25 09:40AM	Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-28-25 08:19AM	CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results (Insider Monkey)
Jan-24-25 08:35AM	Heres Why CareDx (CDNA) Traded Lower in Q4 (Insider Monkey)
Jan-15-25 03:50PM	Wells Fargo upgrades CareDx after a 30% pullback in stock (Investing.com)
Jan-14-25 03:43AM	Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength? (Zacks) -12.05%
Jan-13-25 07:00AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results (Business Wire) +6.09%
Jan-06-25 09:35AM	Implied Volatility Surging for CareDx (CDNA) Stock Options (Zacks)
Dec-18-24 07:05AM	CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) -7.86%
Dec-11-24 07:00AM	TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (PR Newswire)
07:00AM	CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (Business Wire)
Dec-03-24 09:40AM	Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? (Zacks)
Nov-29-24 10:46AM	Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) (Insider Monkey)
Nov-25-24 09:55AM	Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know (Zacks)
Nov-15-24 09:35AM	After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) (Zacks)
Nov-14-24 09:40AM	Are Medical Stocks Lagging CareDx (CDNA) This Year? (Zacks) -5.40%
Nov-12-24 07:05AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
Nov-07-24 09:04AM	Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 (Insider Monkey)
Nov-05-24 01:03PM	Q3 2024 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
02:06AM	CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Nov-04-24 05:03PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance (Business Wire)
Oct-23-24 07:00AM	CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology (Business Wire)
Oct-21-24 07:00AM	CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting (Business Wire)
Oct-17-24 03:06PM	State Street Corp's Strategic Reduction in CareDx Inc Holdings (GuruFocus.com) -6.49%
Oct-16-24 08:17AM	CareDx Reports Strong Q3 2024 Revenue Growth (TipRanks)
Oct-15-24 06:00AM	CareDx Reports Preliminary Financial Results for Third Quarter 2024 (Business Wire) -15.84%
Oct-11-24 04:30PM	CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 03:35PM	CareDx Inc (CDNA) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Adjusted ... (GuruFocus.com) -12.42%
07:05AM	CareDx Appoints Jing Huang Chief Data and AI Officer (Business Wire)
Oct-08-24 04:05PM	CareDx to Host Investor Day on October 15, 2024 (Business Wire)
06:05AM	CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing (Business Wire)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novack Jeffrey Adam	Secretary and General Counsel	Feb 03 '26	Sale	20.56	4,441	91,286	125,364	Feb 04 04:22 PM
JEFFREY NOVACK	Officer	Feb 03 '26	Proposed Sale	20.42	4,441	90,685		Feb 03 04:33 PM
Hanna John Walter JR	President and CEO	Jan 22 '26	Sale	21.16	19,280	408,023	597,405	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 21 '26	Sale	21.00	200	4,200	616,685	Jan 23 05:58 PM
Hanna John Walter JR	President and CEO	Jan 15 '26	Sale	21.05	10,156	213,804	616,885	Jan 20 05:30 PM
JOHN HANNA	Director	Jan 15 '26	Proposed Sale	20.32	29,636	602,204		Jan 15 04:40 PM
Novack Jeffrey Adam	Secretary and General Counsel	Dec 04 '25	Sale	19.17	7,293	139,804	97,925	Dec 05 04:07 PM
JEFFREY NOVACK	Officer	Dec 04 '25	Proposed Sale	18.85	7,293	137,473		Dec 04 04:39 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 07 '25	Sale	15.52	2,688	41,723	105,218	Nov 10 04:14 PM
Jeffrey Adam Novack	Officer	Nov 07 '25	Proposed Sale	15.01	2,688	40,347		Nov 07 04:37 PM
ABHISHEK JAIN	Officer	Nov 05 '25	Proposed Sale	15.77	53,388	842,050		Nov 05 04:21 PM
ABHISHEK JAIN	Officer	Oct 31 '25	Proposed Sale	14.90	9,964	148,464		Oct 31 04:48 PM
Bickerstaff George	Director	Sep 11 '25	Option Exercise	7.96	29,136	231,923	144,266	Sep 12 05:09 PM
Novack Jeffrey Adam	Secretary and General Counsel	Aug 05 '25	Sale	12.79	2,688	34,381	112,930	Aug 07 04:00 PM
Jeffrey Adam Novack	Officer	Aug 05 '25	Proposed Sale	12.60	2,688	33,869		Aug 05 04:27 PM
Maag Peter	Director	Jul 07 '25	Sale	18.58	10,000	185,831	308,846	Jul 10 04:04 PM
Valantine Hannah	Director	Jun 18 '25	Sale	19.16	10,570	202,566	38,994	Jun 23 04:30 PM
Maag Peter	Director	Jun 17 '25	Sale	19.24	10,000	192,420	318,846	Jun 20 04:30 PM
HANNAH VALANTINE	Director	Jun 18 '25	Proposed Sale	19.52	10,570	206,326		Jun 18 04:26 PM
HAGSTROM WILLIAM A	Director	Jun 11 '25	Option Exercise	13.20	19,391	256,052	73,370	Jun 13 05:06 PM
HAGSTROM WILLIAM A	Director	Jun 11 '25	Sale	19.90	19,391	385,918	53,979	Jun 13 05:06 PM
WILLIAM HAGSTROM	Director	Jun 11 '25	Proposed Sale	19.90	19,391	385,918		Jun 11 04:20 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Option Exercise	7.45	30,000	223,441	83,979	May 30 05:57 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Sale	17.45	30,000	523,413	53,979	May 30 05:57 PM
HAGSTROM WILLIAM A	Director	May 28 '25	Proposed Sale	17.63	30,000	528,900		May 28 05:01 PM
COURNOYER CHRISTINE	Director	May 12 '25	Option Exercise	7.96	29,136	231,923	66,181	May 14 05:18 PM
COURNOYER CHRISTINE	Director	May 12 '25	Sale	15.96	29,136	465,022	37,045	May 14 05:18 PM
COURNOYER CHRISTINE	Director	May 12 '25	Proposed Sale	15.96	29,136	465,021		May 12 05:15 PM
Christine M. Cournoyer	Director	May 12 '25	Proposed Sale	15.36	12,000	184,320		May 12 05:10 PM
COURNOYER CHRISTINE	Director	May 06 '25	Sale	14.13	16,700	235,929	37,045	May 08 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	May 05 '25	Sale	14.70	2,688	39,514	121,350	May 07 04:38 PM
Christine M. Cournoyer	Director	May 06 '25	Proposed Sale	15.17	16,700	253,339		May 06 05:00 PM
Jeffrey Adam Novack	Officer	May 05 '25	Proposed Sale	15.00	2,688	40,320		May 05 04:39 PM
Maag Peter	Director	Apr 30 '25	Sale	17.23	13,281	228,796	316,743	May 02 04:49 PM
PETER MAAG	Director	Apr 30 '25	Proposed Sale	18.13	33,281	603,385		Apr 30 04:18 PM
Jain Abhishek	Chief Financial Officer	Apr 07 '25	Sale	17.72	265	4,696	337,418	Apr 09 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	Apr 07 '25	Sale	17.72	924	16,373	126,911	Apr 09 04:30 PM
Bickerstaff George	Director	Mar 10 '25	Sale	18.36	20,000	367,102	103,027	Mar 12 04:30 PM
GEORGE W BICKERSTAFF	Director	Mar 10 '25	Proposed Sale	18.36	20,000	367,102		Mar 10 05:03 PM

Open in Screener

SPOK

Spok Holdings Inc

Feb 11 • 04:00PM ET

13.49

+0.05 0.37 %

Healthcare • Health Information Services • USA • NASD

SPOK Spok Holdings Inc daily Stock Chart

Peers: VZ T TMUS AD INTC CSCO ADTN CMTL ERIC CALX

| Held by: VTI IWM VXF IWN DES VTWO FSMD VOX FDM IWC

Index	RUT	P/E	16.86	EPS (ttm)	0.80	Insider Own	1.89%	Shs Outstand	20.59M	Perf Week	-0.07%
Market Cap	277.87M	Forward P/E	16.25	EPS next Y	0.83	Insider Trans	-48.86%	Shs Float	20.21M	Perf Month	2.90%
Enterprise Value	263.85M	PEG	-	EPS next Q	0.18	Inst Own	59.70%	Short Float	2.12%	Perf Quarter	-0.07%
Income	16.59M	P/S	1.99	EPS this Y	9.59%	Inst Trans	1.12%	Short Ratio	2.56	Perf Half Y	-27.75%
Sales	139.74M	P/B	1.87	EPS next Y	3.75%	ROA	7.78%	Short Interest	0.43M	Perf YTD	2.27%
Book/sh	7.22	P/C	13.00	EPS next 5Y	-	ROE	10.88%	52W High	19.31 -30.14%	Perf Year	-18.83%
Cash/sh	1.04	P/FCF	12.28	EPS past 3/5Y	- -	ROIC	10.82%	52W Low	12.26 10.03%	Perf 3Y	61.56%
Dividend Est.	-	EV/EBITDA	10.92	Sales past 3/5Y	-1.07% -3.00%	Gross Margin	60.23%	Volatility	2.14% 2.18%	Perf 5Y	12.98%
Dividend TTM	1.25 (9.25%)	EV/Sales	1.89	EPS Y/Y TTM	11.33%	Oper. Margin	14.78%	ATR (14)	0.29	Perf 10Y	-20.40%
Dividend Ex-Date	Nov 18, 2025	Quick Ratio	1.21	Sales Y/Y TTM	1.47%	Profit Margin	11.88%	RSI (14)	53.31	Recom	1.00
Dividend Gr. 3/5Y	35.72% 20.11%	Current Ratio	1.21	EPS Q/Q	-14.58%	SMA20	0.51%	Beta	0.39	Target Price	21.00
Payout	171.77%	Debt/Eq	0.05	Sales Q/Q	-2.88%	SMA50	1.97%	Rel Volume	0.62	Prev Close	13.44
Employees	410	LT Debt/Eq	0.03	Earnings	Oct 29 AMC	SMA200	-14.05%	Avg Volume	167.00K	Price	13.49
IPO	May 30, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	-21.05% -5.66%	Trades		Volume	103,484	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-25	Upgrade	B. Riley Securities	Neutral → Buy	$15 → $20
Sep-26-24	Initiated	B. Riley Securities	Neutral	$15
Dec-19-22	Resumed	Lake Street	Buy	$15
Sep-23-22	Initiated	Lake Street	Buy	$14

Feb-04-26 08:30AM	Spok Earns Top Client Satisfaction Scores for Ninth Consecutive Year (Business Wire)
Jan-28-26 07:45AM	AT&T (T) Q4 Earnings and Revenues Beat Estimates (Zacks)
Dec-23-25 08:56AM	Is the Options Market Predicting a Spike in Spok Stock? (Zacks)
Dec-15-25 09:02AM	3 Ultra-High Dividend Yield Picks for the New Year (MarketBeat)
Nov-12-25 08:30AM	15th Annual Spok Survey Highlights Shifting Clinical Communication Opportunities and Obstacles (Business Wire)
08:10PM	Loading…
Nov-04-25 08:10PM	Spok Holdings Inc (SPOK) Q3 2025 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com)
Oct-29-25 05:50PM	Spok Holdings (SPOK) Q3 Earnings and Revenues Miss Estimates (Zacks) -12.52%
04:43PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports Third Quarter 2025 Results (Business Wire)
Oct-28-25 09:59AM	Spok Holdings Inc (SPOK) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-25 10:30AM	Spok Sets Date to Report Third Quarter 2025 Results (Business Wire)
07:45AM	AT&T (T) Q3 Earnings and Revenues Lag Estimates (Zacks)
Oct-09-25 08:30AM	U.S. News & World Report Names Spok-Powered Hospitals to Best Children's Hospitals Honor Roll (Business Wire)
Aug-05-25 12:00PM	Here's Why Spok Holdings (SPOK) is a Great Momentum Stock to Buy (Zacks)
08:30AM	Spok-Powered Hospitals Achieve Recognition on U.S. News & World Reports Best Hospitals Honor Roll (Business Wire)
05:50AM	Loading…
05:50AM	3 Healthcare Stocks Paying the Highest Dividends of 2025 (Motley Fool)
Aug-04-25 12:45PM	3 Reasons Growth Investors Will Love Spok (SPOK) (Zacks)
Aug-01-25 12:00PM	All You Need to Know About Spok (SPOK) Rating Upgrade to Buy (Zacks)
08:50AM	What Makes Spok (SPOK) a Good Fit for 'Trend Investing' (Zacks)
Jul-31-25 03:34AM	Spok Holdings Inc (SPOK) Q2 2025 Earnings Call Highlights: Strong Software Growth and Increased ... (GuruFocus.com) +7.69%
Jul-30-25 05:40PM	Spok Holdings (SPOK) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:38PM	Spok: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports Second Quarter 2025 Results (Business Wire)
Jul-29-25 09:59AM	Spok Holdings Inc (SPOK) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-23-25 03:07PM	Spok Sets Date to Report Second Quarter 2025 Results (Business Wire)
May-01-25 03:19AM	Spok Holdings Inc (SPOK) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +13.18%
Apr-30-25 08:55PM	Spok Holdings, Inc. (SPOK) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:10PM	Spok Holdings (SPOK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:10PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Spok Reports First Quarter 2025 Results (Business Wire)
02:29PM	Loading…
Apr-23-25 02:29PM	Spok Sets Date to Report First Quarter 2025 Results (Business Wire)
07:45AM	AT&T (T) Q1 Earnings Miss Estimates (Zacks)
Apr-10-25 11:07AM	Gogo (GOGO) Moves 15.7% Higher: Will This Strength Last? (Zacks)
Mar-25-25 08:30AM	Spok Achieves Top Client Satisfaction Scores for Eighth Consecutive Year (Business Wire)
Mar-24-25 06:03PM	Spok Holdings (SPOK): Among Top Dividend Stocks that Pay More than the US Average Rental Yield (InsiderMonkey)
Feb-27-25 07:25AM	Q4 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
02:25AM	Spok Holdings Inc (SPOK) Q4 2024 Earnings Call Highlights: Strong Software Growth Amid Revenue ... (GuruFocus.com)
Feb-26-25 06:15PM	Spok Holdings (SPOK) Q4 Earnings and Revenues Miss Estimates (Zacks)
05:17PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-25-25 10:57AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 04:00PM	Spok Sets Date to Report Fourth Quarter and Full Year 2024 Results (Business Wire)
Nov-01-24 07:01AM	Spok Holdings Inc (SPOK) Q3 2024 Earnings Call Highlights: Strong Software Bookings Amid ... (GuruFocus.com)
Oct-30-24 05:35PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Third Quarter 2024 Results (Business Wire)
Oct-29-24 09:16AM	Earnings To Watch: Spok Holdings Inc (SPOK) Reports Q3 2024 Result (GuruFocus.com)
Oct-24-24 09:15AM	Spok Customers Highlighted on U.S. News & World Reports Childrens Best Hospitals Honor Roll (Business Wire)
Oct-23-24 02:00PM	Spok Sets Date to Report Third Quarter 2024 Results (Business Wire)
Oct-22-24 09:15AM	14th Annual Spok Survey Offers Insights Into Evolving Healthcare Communications Challenges and Opportunities (Business Wire)
Aug-21-24 07:01PM	Insider Sale: COO Michael Wallace Sells 25,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Jul-25-24 12:00PM	Spok Holdings (SPOK) Q2 Earnings and Revenues Decline Y/Y (Zacks) -6.50%
09:28AM	Q2 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-24-24 04:48PM	Spok: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 10:54AM	Spok Customers Recognized on U.S. News & World Report's Best Hospitals Honor Roll (Business Wire)
Jul-17-24 10:29AM	Spok Sets Date to Report Second Quarter 2024 Results (Business Wire)
Jul-08-24 09:15AM	Spok Celebrates a Decade of Excellence and Innovation (Business Wire)
May-02-24 12:36PM	Spok Holdings, Inc. (NASDAQ:SPOK) Q1 2024 Earnings Call Transcript (Insider Monkey) -8.08%
08:10AM	Q1 2024 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:40AM	Spok Holdings Inc (SPOK) Q1 2024 Earnings Call Transcript Highlights: A Strong Start with ... (GuruFocus.com)
May-01-24 10:55PM	SPOK Stock Earnings: Spok Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Spok Holdings Inc (SPOK) Reports Strong Q1 2024 Earnings, Surpassing Revenue Expectations (GuruFocus.com)
05:50PM	Spok: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports First Quarter 2024 Results (Business Wire)
Apr-24-24 09:00AM	Spok Sets Date to Report First Quarter 2024 Results (Business Wire)
Apr-02-24 09:15AM	Spok Achieves Top Client Satisfaction Scores for Seventh Consecutive Year (Business Wire)
Mar-30-24 05:00PM	Sub-$20 Superstars: 3 Stocks Ready to Double Your Money (InvestorPlace)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-07-24 09:15AM	Spok to Showcase the Latest Advancements to Top-Rated Secure Healthcare Communication and Collaboration Platform at HIMSS24 (Business Wire)
Mar-06-24 10:00AM	Spok to Present at Sidoti Virtual Investor Conference (Business Wire)
Mar-04-24 11:29PM	Insider Sell: COO Michael Wallace Sells 40,000 Shares of Spok Holdings Inc (SPOK) (GuruFocus.com)
Feb-28-24 05:14PM	3 Underestimated Stocks With 900% Upside Potential (InvestorPlace)
02:27PM	The Dividend Promise: 3 Stocks Set to Deliver in March 2024 (InvestorPlace)
Feb-22-24 11:22AM	Spok Holdings, Inc. (NASDAQ:SPOK) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.25%
06:54AM	Q4 2023 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 05:25PM	Spok: Q4 Earnings Snapshot (Associated Press Finance)
04:45PM	Spok Holdings Inc (SPOK) Reports Revenue Growth and Record Software Bookings in 2023 (GuruFocus.com)
04:10PM	Spok Reports Fourth Quarter And Full Year 2023 Results (Business Wire)
Feb-17-24 02:00PM	Hidden Gems: 3 Stocks Under $20 With 5X Growth Potential by 2027 (InvestorPlace)
Feb-14-24 04:10PM	Spok Sets Date to Report Fourth Quarter and Full Year 2023 Results (Business Wire)
Jan-23-24 06:07PM	3 Small-Cap Stocks Ready to Rocket by 2025 (InvestorPlace)
Dec-25-23 02:53PM	From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune (InvestorPlace)
Dec-01-23 08:59AM	Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio (InvestorPlace)
Nov-16-23 04:05PM	Spok to Present and Host 1x1 Investor Meetings at the 35th Annual Piper Sandler & Co. Healthcare Conference (Business Wire)
Nov-07-23 05:04AM	Director Barbara Byrne Acquires 10,000 Shares of Spok Holdings Inc (GuruFocus.com)
Oct-28-23 01:57PM	Spok Holdings, Inc. (NASDAQ:SPOK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-25-23 06:06PM	Spok Holdings Inc (SPOK) Reports Improved Net Income and Adjusted EBITDA in Q3 2023 (GuruFocus.com)
05:30PM	Spok: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Spok Reports Third Quarter 2023 Results (Business Wire)
Oct-19-23 06:58PM	Spok Sets Date to Report Third Quarter 2023 Results (Business Wire)
Oct-11-23 09:15AM	13th Annual Spok Survey Reveals the State of Healthcare Communications in 2023 (Business Wire)
Aug-02-23 09:15AM	U.S. News and World Report Names Spok Customers to Best Hospitals Honor Roll (Business Wire)
Jul-27-23 10:42PM	Q2 2023 Spok Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +16.70% +10.71%
01:04PM	Why Shares of Spok Are Rising Thursday (Motley Fool)
Jul-26-23 05:22PM	Spok: Q2 Earnings Snapshot (AP Finance)
04:10PM	Spok Reports Second Quarter 2023 Results (Business Wire)
Jul-20-23 11:12AM	Spok Sets Date to Report Second Quarter 2023 Results (Business Wire)
Jun-13-23 09:00AM	Spok to Present and Host 1x1 Investor Meetings at the 13th Annual East Coast Virtual IDEAS Investor Conference on June 21st & 22nd (Business Wire)
May-22-23 09:00AM	Spok set to join Russell 3000® and Russell 2000® Index (Business Wire)
May-08-23 09:35AM	SPOK TO PRESENT AT THE INAUGURAL EF HUTTON GLOBAL CONFERENCE (GlobeNewswire)

Spok Holdings, Inc. engages in the provision of communication solutions. It provides call center operations, clinical alerting and notifications, one-way and advanced two-way wireless messaging services, mobile communications and public safety solutions. The company was founded in 1965 and is headquartered in Plano, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Jan 05 '26	Option Exercise	13.19	8,707	114,845	28,707	Jan 07 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Jan 05 '26	Option Exercise	13.19	22,865	301,589	63,234	Jan 07 04:30 PM
KELLY VINCENT D	President & CEO	Jan 05 '26	Option Exercise	13.19	37,430	493,702	140,247	Jan 07 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Jan 05 '26	Option Exercise	13.19	11,452	151,052	18,487	Jan 07 04:30 PM
Stein Todd J	Director	Sep 04 '25	Sale	18.08	38,008	687,359	497,560	Sep 05 04:30 PM
Stein Todd J	Director	Sep 03 '25	Sale	18.02	43,335	780,921	515,042	Sep 04 04:30 PM
Stein Todd J	Director	Sep 02 '25	Sale	18.05	22,711	409,988	532,932	Sep 04 04:30 PM
Stein Todd J	Director	Aug 25 '25	Sale	17.95	11,766	211,209	543,379	Aug 26 04:30 PM
Stein Todd J	Director	Aug 22 '25	Sale	18.01	8,878	159,924	548,791	Aug 26 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Aug 25 '25	Sale	17.87	10,806	193,118	40,369	Aug 26 04:30 PM
WALLACE MICHAEL W	Officer	Aug 25 '25	Proposed Sale	17.98	11,000	197,780		Aug 25 02:32 PM
KELLY VINCENT D	President & CEO	Aug 21 '25	Sale	17.69	25,000	442,175	102,817	Aug 22 04:30 PM
Stein Todd J	Director	Aug 20 '25	Sale	18.10	13,208	239,053	552,875	Aug 22 04:30 PM
KELLY VINCENT D	Officer	Aug 21 '25	Proposed Sale	17.69	25,000	442,167		Aug 21 05:04 PM
Stein Todd J	Director	Aug 18 '25	Sale	18.37	28,366	521,045	558,951	Aug 20 04:30 PM
Stein Todd J	Director	Aug 14 '25	Sale	18.50	63,170	1,168,569	587,372	Aug 18 04:30 PM
Stein Todd J	Director	Aug 15 '25	Sale	18.44	33,416	616,047	572,000	Aug 18 04:30 PM
Braeside Capital II, L.P.	Affiliate of Director	Aug 14 '25	Proposed Sale	18.76	189,250	3,550,330		Aug 14 06:26 PM
Braeside Capital, L.P.	Affiliate of Director	Aug 14 '25	Proposed Sale	18.76	158,000	2,964,080		Aug 14 05:27 PM
Stein Todd J	Director	Aug 12 '25	Sale	18.45	41,418	764,021	31,947	Aug 14 04:30 PM
Stein Todd J	Director	Aug 13 '25	Sale	18.48	31,947	590,313	0	Aug 14 04:30 PM
Stein Todd J	Director	Aug 04 '25	Sale	18.63	70,020	1,304,613	77,865	Aug 06 04:30 PM
Stein Todd J	Director	Aug 05 '25	Sale	18.61	4,500	83,733	73,365	Aug 06 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Aug 05 '25	Sale	18.28	14,736	269,389	7,035	Aug 06 04:30 PM
KELLY VINCENT D	President & CEO	Aug 04 '25	Sale	18.53	30,000	555,795	127,817	Aug 05 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Aug 04 '25	Sale	18.73	7,457	139,667	21,771	Aug 05 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Aug 04 '25	Sale	18.49	10,000	184,869	51,175	Aug 05 04:30 PM
Rice Calvin	Officer	Aug 05 '25	Proposed Sale	18.36	14,736	270,552		Aug 05 02:04 PM
KELLY VINCENT D	Officer	Aug 04 '25	Proposed Sale	18.53	30,000	555,794		Aug 04 04:42 PM
Braeside Investments, LLC	Affiliate of Director (1)	Aug 04 '25	Proposed Sale	18.51	147,885	2,737,351		Aug 04 04:25 PM
Rice Calvin	Officer	Aug 04 '25	Proposed Sale	18.73	7,457	139,667		Aug 04 12:21 PM
WALLACE MICHAEL W	Officer	Aug 04 '25	Proposed Sale	18.36	10,000	183,600		Aug 04 12:09 PM
COURNOYER CHRISTINE	Director	May 09 '25	Sale	16.46	5,000	82,303	15,088	May 12 04:30 PM
Christine M. Cournoyer	Director	May 09 '25	Proposed Sale	16.54	5,000	82,700		May 09 04:03 PM
WALLACE MICHAEL W	Chief Operating Officer	May 07 '25	Sale	16.53	6,000	99,167	61,175	May 08 04:30 PM
KELLY VINCENT D	President & CEO	May 06 '25	Sale	16.40	30,000	492,054	157,817	May 07 04:30 PM
WALLACE MICHAEL W	Officer	May 07 '25	Proposed Sale	16.55	6,000	99,300		May 07 03:12 PM
KELLY VINCENT D	Officer	May 06 '25	Proposed Sale	16.40	30,000	492,052		May 06 04:47 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Mar 13 '25	Sale	16.02	16,253	260,415	20,000	Mar 14 04:30 PM
Stein Todd J	Director	Mar 10 '25	Sale	16.58	73,652	1,220,819	608,154	Mar 12 04:30 PM
Stein Todd J	Director	Mar 11 '25	Sale	16.36	3,969	64,949	606,329	Mar 12 04:30 PM
Rice Calvin	Chief Financial Officer & CAO	Mar 07 '25	Option Exercise	16.85	13,006	219,151	33,460	Mar 07 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Mar 07 '25	Option Exercise	16.85	34,682	584,392	77,105	Mar 07 04:30 PM
Woods-Keisling Sharon	Corporate Secretary, Treasurer	Mar 07 '25	Option Exercise	16.85	10,838	182,620	37,243	Mar 07 04:30 PM
KELLY VINCENT D	President & CEO	Mar 07 '25	Option Exercise	16.85	57,803	973,981	204,366	Mar 07 04:30 PM
Woods-Keisling Sharon	Officer	Mar 06 '25	Proposed Sale	16.38	16,253	266,224		Mar 06 03:02 PM
Stein Todd J	Director	Mar 03 '25	Sale	16.75	60,182	1,007,958	642,033	Mar 05 04:30 PM
WALLACE MICHAEL W	Chief Operating Officer	Mar 04 '25	Sale	16.53	10,000	165,331	42,423	Mar 05 04:30 PM
COURNOYER CHRISTINE	Director	Mar 04 '25	Sale	16.51	12,000	198,085	18,567	Mar 05 04:30 PM
Christine M. Cournoyer	Director	Mar 04 '25	Proposed Sale	16.50	12,000	198,060		Mar 04 05:28 PM
KELLY VINCENT D	President & CEO	Mar 03 '25	Sale	16.73	30,000	501,897	146,563	Mar 04 04:30 PM
WALLACE MICHAEL W	Officer	Mar 04 '25	Proposed Sale	16.59	10,000	165,900		Mar 04 12:53 PM
KELLY VINCENT D	Officer	Mar 03 '25	Proposed Sale	16.73	30,000	501,897		Mar 03 04:31 PM
Braeside Capital II, L.P.	Affiliate of Director	Mar 03 '25	Proposed Sale	16.54	72,000	1,190,880		Mar 03 04:02 PM
Braeside Capital, L.P.	Affiliate of Director	Mar 03 '25	Proposed Sale	16.54	95,000	1,571,300		Mar 03 04:00 PM

CDNA

Caredx Inc

SPOK

Spok Holdings Inc

Upgrade your FINVIZ experience